Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • wilderguide wilderguide Sep 19, 2013 2:46 PM Flag

    NCT01100619 update

    $$$$
    "Cabozantinib in combination with Avandia in patients with solid tumors"
    Also on 9/17/13, this trial updated with "This trial has been completed"
    I understand that a high percentage of cancer patients present with co-morbid diabetes as well, so these results - when presented - have some noteworthy potential. There are many noteworthy recent updates at clinicltrialsdotgov, and I won't bore you with further postings today, but I expect we are due a windfall of data.
    GLTA

 
EXEL
5.73+0.19(+3.43%)Jul 31 4:00 PMEDT